View some of our active clinical trials below, including a summary of the trial protocol and the Principal Investigator/Eye Doctor in charge of the trial.
Our Eye Doctors play an essential role in conducting clinical trials. Are you a medical provider interested in learning more about clinical trials and playing a role in advancing medical knowledge? You can learn more about these clinical trials from any of our PIs, and discuss how you can refer patients to these and other clinical trials.
*Patients would be referred to our research facility only, located in a separate building from The Eye Care Institute, and returned to you for regular eye care.
Meibomian Gland Dysfunction
A Phase 3, Multicenter, Vehicle-Controlled, Randomized Study to Evaluate the Efficacy, Safety and Tolerability of AZR-MD-001 in Patients with Abnormal Meibomian Gland Function Associated Symptoms of Dry Eye Disease (DED)
Guruprasad Pattar, M.D.
Principal Investigator
The Eye Care Institute
Butchertown Clinical Trials
Thyroid Eye Disease
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20SC Administered by Prefilled syringe in Adult Participants with Thyroid Eye Disease.
Guruprasad Pattar, M.D.
Principal Investigator
The Eye Care Institute
Butchertown Clinical Trials
Decreased VA Under Mesopic Conditions After Refractive Surgery
Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of POS (0.75% Phentolamine Ophthalmic Solution) in Subjects Who Have Previously Had Keratorefractive Surgery and Have Decreased Visual Acuity Under Mesopic Conditions
John Meyer M.D.
Principal Investigator
The Eye Care Institute
Butchertown Clinical Trials
Dry Age-Related Macular Degeneration
A Phase 3, Randomized, Double- Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects who have Dry Age-Related Macular Degeneration (Dry AMD)
Victor Neamtu, M.D.
Principal Investigator
The Eye Care Institute
Butchertown Clinical Trials
Blepharitis
A Randomized, Double-masked, Vehicle-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects with Blepharitis
John Meyer M.D.
Principal Investigator
The Eye Care Institute
Butchertown Clinical Trials
Open Angle Glaucoma
A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the Miniject CS627 Implant in Subjects with Open Angle Glaucoma
Brennan Greene, M.D.
Principal Investigator
The Eye Care Institute
Butchertown Clinical Trials
